LIMES Schlosskliniken AG

XETRA LIK.DE

LIMES Schlosskliniken AG Shareholders' Equity for the year ending December 31, 2023: USD 16.70 M

LIMES Schlosskliniken AG Shareholders' Equity is USD 16.70 M for the year ending December 31, 2023, a 40.59% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

LIMES Schlosskliniken AG Shareholders' Equity for the year ending December 31, 2022 was USD 11.88 M, a 65.37% change year over year.
LIMES Schlosskliniken AG Shareholders' Equity for the year ending December 31, 2021 was USD 7.18 M, a 119.44% change year over year.
LIMES Schlosskliniken AG Shareholders' Equity for the year ending December 31, 2020 was USD 3.27 M, a -13.55% change year over year.
LIMES Schlosskliniken AG Shareholders' Equity for the year ending December 31, 2019 was USD 3.79 M, a 203.11% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

XETRA: LIK.DE

LIMES Schlosskliniken AG

CEO	Dr. Gert Michael Frank
IPO Date	March 19, 2019
Location	Germany
Headquarters	Kaiser-Wilhelm-Ring 26
Employees	210
Sector	Healthcare
Industries Mental Health Hospitals & Clinics

Description

LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.

Key trends

Past 5 years